PEACCEL
Peaccel is an AI company focused on the Life Sciences sector, establishing strategic partnerships with chemical, biotech, and pharma companies, as well as innovative startups. Their core offering is the innov’SAR Artificial Intelligence Platform, designed to accelerate drug discovery from 'hit to lead' and optimize biologicals like peptides, proteins, enzymes, and antibodies. The platform utilizes a data-centric approach, screening up to a billion mutants daily, and differentiating itself through its ability to predict outside-the-box and handle complex biological challenges like epistasis. Peaccel emphasizes a transparent reporting system and a scientific team with extensive expertise in bioinformatics and machine learning, aiming to develop sustainable solutions and efficiently evaluate project feasibility.
PEACCEL
Peaccel is an AI company focused on the Life Sciences sector, establishing strategic partnerships with chemical, biotech, and pharma companies, as well as innovative startups. Their core offering is the innov’SAR Artificial Intelligence Platform, designed to accelerate drug discovery from 'hit to lead' and optimize biologicals like peptides, proteins, enzymes, and antibodies. The platform utilizes a data-centric approach, screening up to a billion mutants daily, and differentiating itself through its ability to predict outside-the-box and handle complex biological challenges like epistasis. Peaccel emphasizes a transparent reporting system and a scientific team with extensive expertise in bioinformatics and machine learning, aiming to develop sustainable solutions and efficiently evaluate project feasibility.